Skin and connective tissue diseases Skin and Connective Tissue Diseases Atopic dermatitis
Conditions
Interventions
1. Primary care nurse-led clinic
2. Standard care
Sponsors
NHS R&D Regional Programme Register - Department of Health (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 6 months up to 16th birthday 2. Diagnosis of atopic eczema made using British Association of Dermatology guidelines 3. New cases and patients requesting repeat prescription for medication issued for a diagnosis of atopic eczema.
Exclusion criteria
Exclusion criteria: 1. Poorly controlled asthma defined as patient receiving oral steroids or having a change in dose of medication in the 4 weeks prior to recruitment (children with stable asthma will be included). 2. Children from the same family of a child who has already participated in the trial (to eliminate the risk of contamination of intervention and control groups).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life will be assessed using validated instruments: 1. Family Impact Questionnaire (FIQ). 2. Infant Eczema Life Quality Index questionnaire (IELQI) for children aged 6 months to 4 years. 3. Children's Dermatology Life Quality Index Questionnaire (CDLQI) for children aged 4-16. 4. Change in the Family Dermatitis Index (FDI), Infants Eczema Life Quality Index (IELQI) and Children's Dermatology Life Quality Index (CDLQI) recorded at baseline and at 4 weeks and 12 weeks post-intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed